AzTrials
AzTrials

HealthyWBB2NCT02736331

Different Types of Fruits on Metabolic Function and Cognitive Performance

A study testing Treatment 1 and Treatment 2 in people with Healthy, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary objective is to assess the effect of the intake of different types of fruits on memory and attention. Secondary objective is to assess effect of intake of different types of fruits on metabolic markers, including glucose, insulin, total cholesterol and triglyceride and the pharmacokinetic profile of the… Read more about this study

Who is it for?
Ages 40 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Treatment 1 and Treatment 2
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
2 Mar 2016to 30 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Subject is male or female aged between 40 and 65 years of age
  • Subject has BMI between 18.5 and 34.9 kg/m2, (inclusive) at screening visit
  • Fasting blood sugar less than 126 mg/dL
  • Average Blood pressure less than 160/100 mmHg
  • Subject is willing to maintain a stable body weight and to follow his/her regular diet and physical activity patterns throughout the study period.
  • Subject is willing to refrain from vigorous physical activity and consumption of alcoholic and/or caffeinated beverages 24 h prior to each test day
Show all 9Show fewer
  • Subject does not smoke or has abstained from smoking for at least 2 years
  • No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
  • Not taking any medications or dietary supplements that would interfere with outcomes of the study.

Who cannot join

  • • Subject currently smokes or has smoked within the past 2 years
  • Subject works overnight i.e. the night shift
  • Subjects who have a significant sleep disorder, a traumatic brain injury, have a learning disability or attention deficit disorder or any psychiatric or neurological disturbances
  • Subject is color blind, has impaired cognitive performance on the flanker test (score <60 at screening) or has a vein access score <7
  • Men and women with known or suspected food intolerance, allergies or hypersensitivity to the study materials or closely related compounds
  • Men and women known to have/diagnosed with diabetes mellitus
Show all 20Show fewer
  • Men and women with a fasting blood glucose concentration ≥126 mg/dL
  • Average blood pressure > 160/100 mmHg during screening visit
  • Men and women with documented vascular disease, e.g., heart failure, myocardial infarction, stroke, angina, related surgeries
  • Men and women with cancer other than non-melanoma skin cancer in previous 2 years
  • Men and women who are taking medication or dietary supplements that may interfere with the study procedures or the endpoints of the study (e.g. antioxidants, anti-inflammatory medications, antidepressant medications, oral and injectable hypoglycemic medications, GI medications, antibiotics, diuretics, adrenergic blockers etc.) Subjects may choose to go off dietary supplements (requires 30 days washout)
  • Men and women taking antibiotics within 5 days of study start
  • Men and women who have donated blood/plasma within 3 months of the screening visit and blood donors/participants for whom participation in this study will result in having donated more than 1500 milliliters of blood in the previous 12 months
  • Substance (alcohol or drug) abuse within the last 2 years
  • Excessive coffee and tea consumption (> 4 cups/day)
  • Unstable body weight fluctuations of >4.5kg (9.9lbs) in the past 4 weeks
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study and women who are lactating.
  • Men and women whom investigator is uncertain about subject's capability or willingness to comply with protocol requirements
  • Women who are taking unstable dose and brand of hormonal contraceptives and/or stable dose and brand less than 6 months.
  • Men and women who do excessive exercise regularly or are athlete

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Clinical Nutrition Research Center

    Chicago, Illinois, 60616

Other trials in United States

About this study

Official title: The Effect of Different Types of Fruits on Metabolic Function and Cognitive Performance

Primary objective is to assess the effect of the intake of different types of fruits on memory and attention.

Secondary objective is to assess effect of intake of different types of fruits on metabolic markers, including glucose, insulin, total cholesterol and triglyceride and the pharmacokinetic profile of the anthocyanins.

Read the detailed description

The trial is designed as a randomized 2-arm, placebo-controlled, within-subjects crossover utilizing a multiple sampling, repeated measures paradigm to investigate the effects of consumption of different types of fruits on cognitive performance and metabolic responses. This trial will test 2 treatment conditions in forty men and women who will be enrolled into the study.

Each subject will be asked to come for one screening visit, a pre-study visit, and two dinner pick-ups the day before each of the two test visits and 2 test visits. Participation in this study will last approximately four weeks.

The initial screening visit will provide the subject with the informed consent document and determine eligibility through anthropometric measurements, vital signs, fasting blood glucose test , vein assessment, color test and completion of a survey relate to general eating, health, and exercise habits. In addition, subjects will take brief tests of attention and memory to ensure capability and willingness to perform tests during subsequent research visits. Eligible subjects will be trained and instructed to record all food and beverages consumed for a 3-day period (one weekend day and two weekdays) on food record diaries. At the pre-study visit, subjects will be instructed to follow a strictly limited polyphenolic diet for 7 days prior to the study and throughout their participation time, while maintaining their usual diet pattern and physical activity. A dinner meal will be provided the day before the study visit.

At each test visit, subjects will arrive at the clinic after fasting 8 to 12 hours and in a well-hydrated state. After confirming compliance with protocol, anthropometric measurements and vital signs will be taken along with a finger prick for fasting blood glucose and a catheter placement .

Fasting baseline blood sample from a catheter will be collected after which baseline cognitive performance measures will be assessed. After completing baseline measures, subjects will receive a standard breakfast meal along with a beverage containing different fruits according to the randomization sequence. Additional blood samples will be taken at 30, 60, 120, 180, 240, 300, 360, and 480 minutes after the start of the breakfast meal. Additional cognitive tests will be performed at the 120, 240, 360, and 480 minute time points. A standardized lunch will be provided between the 360 and 480 minute time points.

Subject will come to the clinic for 2 test day visits; all procedures will be the same except for the treatment (the test or control treatment).

Conditions
Healthy
Being tested
Treatment 1, Treatment 2
Keywords
Cognitive performance, Metabolic control, Pharmacokinetic profile, Anthocyanins

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment 1Dietary supplement

    Treatment 1 Beverage

  • Treatment 2Dietary supplement

    Treatment 2 Beverage

Study groups in NCT02736331
Study groupRoleWhat they receive
Treatment 1 BeverageExperimentalTreatment 1
Receives: Dietary Supplement: Treatment 1
Treatment 2 BeveragePlacebo comparatorTreatment 2
Receives: Dietary Supplement: Treatment 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in memory function using the Montreal Cognitive Assessment after intake of different types of fruits

    Sum all sub-scores of the Montreal Cognitive Assessment

    Measured: 8 hours Postprandial Study

Secondary outcomes (4)
  1. Changes in plasma glucose concentrations after intake of different types of fruits

    plasma glucose concentrations after intake of different types of fruits

    Measured: 8 hours Postprandial Study

  2. Changes in plasma insulin concentrations after intake of different types of fruits

    insulin concentrations after intake of different types of fruits

    Measured: 8 hours Postprandial Study

  3. Changes in plasma Triglycerides Concentrations after intake of different types of fruits

    Plasma Triglycerides Concentrations after intake of different types of fruits

    Measured: 8 hours Postprandial Study

  4. Changes in plasma Total Cholesterol Concentrations after intake of different types of fruits

    plasma Total Cholesterol Concentrations after intake of different types of fruits

    Measured: 8 hours Postprandial Study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2016 (estimated)
  2. Study start2 Mar 2016
  3. Primary completion30 Oct 2019
  4. Study completion30 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02736331
Sponsor's protocol ID
IRB2015-105
Acronym
WBB2
Status last verified
Jul 2021
First submitted
31 Mar 2016
Last updated
27 Jul 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Treatment 1 and Treatment 2 in people with Healthy, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in memory function using the Montreal Cognitive Assessment after intake of different types of fruits (time frame: 8 hours Postprandial Study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
WBB2 Clinical Trial NCT02736331 | AzTrials